[ad_1]
Global Retail Goliath Walmart has joined a consortium that is trying to create a chain of chains to track pharmaceutical supply chains.
A spokesman for the company confirmed to CoinDesk that Walmart had joined MediLedger, but had not commented.
MediLedger aims to create an "open and decentralized network for the pharmaceutical supply chain", designed to cope with the tightening of regulations governing supply chains for medicines and medicines. That said, according to the MediLedger website, network nodes are managed and operated by industry participants. Therefore, this does not seem completely open and decentralized.
The US Food and Drug Agency (FDA) Drug Supply Chain Chain Security Act states that pharmaceutical companies must "set up an electronic and interoperable system to identify and locate certain prescription drugs as they are distributed in the United States ". MediLedger hopes that Ethereum's private branch, intended for businesses, will provide part of the solution.
Indeed, companies must be ready to give the system the opportunity to find a solution, however. With this news, Walmart joins a host of leading pharmaceutical companies such as Pfizer, McKesson Corporation, AmerisourceBergen and Premier Inc, all of which are testing MediLedger.
It turns out that this is not Walmart's first foray into supply chains based on block chains.
With the epidemics of E. On the rise last September, Walmart began telling all of its green suppliers to start tracking their products in the blockchain within a year.
Given the FDA's drug supply regulations, Big Pharma certainly needs a digital system to track and track their delivery. But it remains to be seen if the blockchain will come first.
Posted on June 3, 2019 – 13:33 UTC
[ad_2]
Source link
